Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images∗∗A list of participating investigators appears in the Appendix.
- 1 September 2000
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 86 (6), 669-674
- https://doi.org/10.1016/s0002-9149(00)01050-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent: Results of a phase III multicenter trialJournal of the American College of Cardiology, 1998
- Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiogramsJournal of the American College of Cardiology, 1998
- Myocardial imaging with a new transpulmonary lipid-fluorocarbon echo contrast agent: Experimental studies in pigsAmerican Heart Journal, 1996
- MRX 115, an echocardiographic contrast agent, produces myocardial opacification after intravenous injection in primates: Studies before and after occlusion of left anterior descending coronary arteryAcademic Radiology, 1996
- Preclinical studies of MRX-115: Safety evaluations of a myocardial perfusion agentAcademic Radiology, 1996
- Intravenous perfluoropropane-exposed sonicated dextrose albumin produces myocardial ultrasound contrast that correlates with coronary blood flowJournal of the American Society of Echocardiography, 1995
- Intravenous albunex during dobutamine stress echocardiography: Enhanced localization of left ventricular endocardial bordersAmerican Heart Journal, 1995
- Visually discernible myocardial echocardiographic contrast after intravenous injection of sonicated dextrose albumin microbubbles containing high molecular weight, less soluble gasesJournal of the American College of Cardiology, 1995
- Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: Results of the phase III albunex multicenter trialJournal of the American College of Cardiology, 1993
- Safety and efficacy of a new transpulmonary ultrasound contrast agent: Initial multicenter clinical resultsJournal of the American College of Cardiology, 1990